Hematocrit Level as a Marker of Outcome in ST-Segment Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 105, Issue 4, 2010, Pages 435-440

  Greenberg, Gabriel ^a   Assali, Abid ^a   Vaknin Assa, Hanna ^a   Brosh, David ^a   Teplitsky, Igal ^a   Fuchs, Shmuel ^a   Battler, Alexander ^a   Kornowski, Ran ^a   Lev, Eli I ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ADULT; AGED; ANEMIA; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTOSIS; FEMALE; HEART INFARCTION; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANEMIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEMATOCRIT; HUMANS; ISRAEL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; POLYCYTHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SURVIVAL RATE;

EID: 75349104476     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.016     Document Type: Article

References (14)

1. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B., Murphy S.A., McCabe C.H., Gibson C.M., and Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
2. Carallo C., Pujia A., Irace C., De Franceschi M.S., Motti C., and Gnasso A. Whole blood viscosity and haematocrit are associated with internal carotid atherosclerosis in men. Coron Artery Dis 9 (1998) 113-117
3. Gagnon D.R., Zhang T.J., Brand F., and Kannel W.B. Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J 127 (1994) 674-682
4. Wannamethee G., Perry I.J., and Shaper A.G. Haematocrit, hypertension and risk of stroke. J Intern Med 235 (1994) 163-168
5. Kershenovich S., Modiano M., and Ewy G.A. Markedly decreased coronary blood flow in secondary erythrocytosis. Am Heart J 123 (1992) 521-523
6. Lowe G.D., and Forbes C.D. Blood rheology and thrombosis. Clin Haematol 10 (1981) 343-367
7. Dormandy J.A., Hoare E., Colley J., Arrowsmith D.E., and Dormandy T.L. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. BMJ 4 (1973) 576-581
8. WHO Scientific Group. Nutritional Anemias: Report of A Scientific Group (1968), World Health Organization, Geneva
9. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W., and Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
10. Groenveld H.F., Januzzi J.L., Damman K., van Wijngaarden J., Hillege H.L., van Veldhuisen D.J., and van der Meer P. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J Am Coll Cardiol 52 (2008) 818-827
11. Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., Mehran R., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T., Turco M., Cohen D.A., Negoita M., Lansky A.J., and Stone G.W. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44 (2004) 547-553
12. Go A.S., Yang J., Ackerson L.M., Lepper K., Robbins S., Massie B.M., and Shlipak M.G. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) study. Circulation 113 (2006) 2713-2723
13. Wu W.C., Schifftner T.L., Henderson W.G., Eaton C.B., Poses R.M., Uttley G., Sharma S.C., Vezeridis M., Khuri S.F., and Friedmann P.D. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 297 (2007) 2481-2488
14. Aoki J., Lansky A.J., Mehran R., Moses J., Bertrand M.E., McLaurin B.T., Cox D.A., Lincoff A.M., Ohman E.M., White H.D., Parise H., Leon M.B., and Stone G.W. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation 119 (2009) 687-698